Similarly, ovarian ablation has been shown to reduce recurrence and mortality in breast cancer patients [23,24,28,29], and prophylactic oophorectomy has been shown to significantly reduce breast cancer incidence in high-risk women, including BRCA1 and BRCA2 mutation carriers [30-33]. This evidence concerns the gene BRCA2 and breast cancer.